{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:21:40Z","timestamp":1756902100413,"version":"3.44.0"},"reference-count":25,"publisher":"The Pediatric Pharmacy Association","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"abstract":"<jats:p>\n          <jats:italic>Mycoplasma hominis<\/jats:italic> (<jats:italic>M hominis<\/jats:italic>) is a rare cause of neonatal bacterial meningitis. Treatment can be challenging because of <jats:italic>M hominis<\/jats:italic>' intrinsic antibiotic resistance and the difficulty in accessing antimicrobial susceptibility testing. In this report, we describe an extremely preterm male infant with seizures who had a subsequent diagnosis of <jats:italic>M hominis<\/jats:italic> meningitis. Because of severity of illness, doxycycline (4 mg\/kg IV every 24 hours) and moxifloxacin (5 mg\/kg IV every 24 hours) were started empirically. Repeat cerebrospinal fluid cultures were negative and showed decreasing pleiocytosis. Given the concentration-dependent killing of moxifloxacin and concern for endovascular infection from a concomitant cerebral venous sinus thrombosis, serum concentrations of moxifloxacin were obtained to estimate pharmacokinetic and pharmacodynamic parameters. These were compared to the targets described in other case reports of <jats:italic>M hominis<\/jats:italic> meningitis. The maximum serum concentration (C<jats:sub>max<\/jats:sub>) was 2.5 mg\/L, volume of distribution was 2.2 L\/kg, clearance was 0.18 L\/kg\/hr, terminal half-life was 8.6 hours, and area-under-the-concentration-time curve (AUC) was 28.1 mg\u2022hr\/L. Using the range of minimum inhibitory concentrations (MICs) reported in the literature, the estimated C<jats:sub>max<\/jats:sub>\/MIC for this patient was 21 to 158 (target C<jats:sub>max<\/jats:sub>\/MIC: &gt;10) and AUC\/MIC was 234 to 1757 (target AUC\/MIC: \u2265100). Doxycycline and moxifloxacin were continued for 6 weeks. No adverse events to moxifloxacin or doxycycline were observed in the NICU. This report describes the successful treatment of <jats:italic>M hominis<\/jats:italic> neonatal meningitis and adds to the knowledge of pharmacokinetic and pharmacodynamic parameters of moxifloxacin in neonates. Additional data will help to confirm the role for routine therapeutic drug monitoring of moxifloxacin in neonates.<\/jats:p>","DOI":"10.5863\/1551-6776-26.8.857","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:52:45Z","timestamp":1636591965000},"page":"857-862","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic Drug Monitoring of Moxifloxacin to Guide Treatment of Mycoplasma hominis Meningitis in an Extremely Preterm Infant"],"prefix":"10.5863","volume":"26","author":[{"given":"Telford","family":"Yeung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura K.","family":"Erdman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Smiljkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waison","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asaph","family":"Rolnitsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaun K.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amr","family":"El Shahed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudaina","family":"Banihani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ari","family":"Bitnun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","reference":[{"key":"i1551-6776-26-8-857-b1","series-title":"Infections in the Central Nervous System","article-title":"Mycoplasmal and ureaplasmal infections","volume":"420","year":"2014","unstructured":"Bitnun\n              A,\n            \n            \n              Richardson\n              S.\n            \n          \n          Mycoplasmal and ureaplasmal infections.\n\t\t\t\t\tIn:ScheldMW,WhitleyRJ,MarraCM,eds.Infections in the Central Nervous System.\n\t\t\t\t\t4th ed.\n\t\t\t\t\tPhiladelphia, PA:\n\t\t\t\t\tLippincott Williams & Wilkens;\n\t\t\t\t\t2014:\n\t\t\t\t\t420\u2013\n\t\t\t\t\t433."},{"issue":"4","key":"i1551-6776-26-8-857-b2","series-title":"Semin Fetal Neonat Med","first-page":"190","article-title":"Congenital and opportunistic infections: Ureaplasma and Mycoplasma hominis","volume":"14","year":"2009","unstructured":"Waites\n              KB,\n            \n            \n              Schelonka\n              RL,\n            \n            \n              Xiao\n              L,\n            \n          \n          .\n\t\t\t\t\tCongenital and opportunistic infections: Ureaplasma and Mycoplasma hominis.\n\t\t\t\t\tSemin Fetal Neonat Med.\n\t\t\t\t\t2009;\n\t\t\t\t\t14(\n\t\t\t\t\t4)\n\t\t\t\t\t190\u2013\n\t\t\t\t\t199."},{"issue":"4","key":"i1551-6776-26-8-857-b3","series-title":"J Infect","first-page":"338","article-title":"Mycoplasma hominis meningitis in a neonate: case report and review","volume":"57","year":"2008","unstructured":"Hata\n              A,\n            \n            \n              Honda\n              Y,\n            \n            \n              Asada\n              K,\n            \n          \n          .\n\t\t\t\t\tMycoplasma hominis meningitis in a neonate: case report and review.\n\t\t\t\t\tJ Infect.\n\t\t\t\t\t2008;\n\t\t\t\t\t57(\n\t\t\t\t\t4):\n\t\t\t\t\t338\u2013\n\t\t\t\t\t343."},{"issue":"2","key":"i1551-6776-26-8-857-b4","series-title":"Pediatr Infect Dis J","first-page":"197","article-title":"Pharmacokinetics of moxifloxacin in an infant with Mycoplasma hominis meningitis","volume":"31","year":"2012","unstructured":"Watt\n              KM,\n            \n            \n              Massaro\n              MM,\n            \n            \n              Smith\n              B,\n            \n          \n          .\n\t\t\t\t\tPharmacokinetics of moxifloxacin in an infant with Mycoplasma hominis meningitis.\n\t\t\t\t\tPediatr Infect Dis J.\n\t\t\t\t\t2012;\n\t\t\t\t\t31(\n\t\t\t\t\t2):\n\t\t\t\t\t197\u2013\n\t\t\t\t\t199."},{"issue":"11","key":"i1551-6776-26-8-857-b5","series-title":"Lancet Infect Dis","first-page":"e261","article-title":"Neonate with Mycoplasma hominis meningoencephalitis given moxifloxacin","volume":"16","year":"2016","unstructured":"Wildenbeest\n              JG,\n            \n            \n              Said\n              I,\n            \n            \n              Jaeger\n              B,\n            \n          \n          .\n\t\t\t\t\tNeonate with Mycoplasma hominis meningoencephalitis given moxifloxacin.\n\t\t\t\t\tLancet Infect Dis.\n\t\t\t\t\t2016;\n\t\t\t\t\t16(\n\t\t\t\t\t11):\n\t\t\t\t\te261\u2013\n\t\t\t\t\te266."},{"issue":"5","key":"i1551-6776-26-8-857-b6","series-title":"Rev Med Clin Condes","first-page":"615","article-title":"Optimizing antimicrobial pharmacodynamics: a guide for your stewardship program","volume":"27","year":"2016","unstructured":"Kuti\n              JL.\n            \n          \n          Optimizing antimicrobial pharmacodynamics: a guide for your stewardship program.\n\t\t\t\t\tRev Med Clin Condes.\n\t\t\t\t\t2016;\n\t\t\t\t\t27(\n\t\t\t\t\t5):\n\t\t\t\t\t615\u2013\n\t\t\t\t\t624."},{"issue":"1","key":"i1551-6776-26-8-857-b7","series-title":"J Infect","first-page":"109","article-title":"Mycoplasma hominis meningitis in a preterm infant","volume":"15","year":"1987","unstructured":"Kirk\n              N,\n            \n            \n              Kovar\n              I.\n            \n          \n          Mycoplasma hominis meningitis in a preterm infant.\n\t\t\t\t\tJ Infect.\n\t\t\t\t\t1987;\n\t\t\t\t\t15(\n\t\t\t\t\t1):\n\t\t\t\t\t109\u2013\n\t\t\t\t\t110."},{"issue":"11","key":"i1551-6776-26-8-857-b8","series-title":"Pediatr Infect Dis J","first-page":"795","article-title":"Mycoplasma hominis meningitis in a premature infant","volume":"7","year":"1988","unstructured":"McDonald\n              JC,\n            \n            \n              Moore\n              DL.\n            \n          \n          \n            Mycoplasma hominis meningitis in a premature infant.\n\t\t\t\t\tPediatr Infect Dis J.\n\t\t\t\t\t1988;\n\t\t\t\t\t7(\n\t\t\t\t\t11):\n\t\t\t\t\t795\u2013\n\t\t\t\t\t798."},{"issue":"8","key":"i1551-6776-26-8-857-b9","series-title":"Clin Microbiol Infect","first-page":"801","article-title":"Activity of Moxifloxacin against the Urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis, Mycoplasma genitalium and Chlamydia Trachomatis","volume":"14","year":"2008","unstructured":"B\u00e9b\u00e9ar\n              CM,\n            \n            \n              de Barbeyrac\n              B,\n            \n            \n              Pereyre\n              S,\n            \n            \n              Renaudin\n              H\n            \n            .\n\t\t\t\t\t\n          Activity of Moxifloxacin against the Urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis, Mycoplasma genitalium and Chlamydia Trachomatis.\n\t\t\t\t\tClin Microbiol Infect2008;\n\t\t\t\t\t14(\n\t\t\t\t\t8):\n\t\t\t\t\t801\u2013\n\t\t\t\t\t805."},{"issue":"2","key":"i1551-6776-26-8-857-b10","series-title":"J Microbiol Methods","first-page":"285","article-title":"In vitro comparison of agar and microbroth dilution methods for determination of MICs for Mycoplasma hominis","volume":"60","year":"2005","unstructured":"Hilliard\n              NJ,\n            \n            \n              Duffy\n              LB,\n            \n            \n              Crabb\n              DM,\n            \n            \n              Waites\n              KB.\n            \n          \n          In vitro comparison of agar and microbroth dilution methods for determination of MICs for Mycoplasma hominis.\n\t\t\t\t\tJ Microbiol Methods.\n\t\t\t\t\t2005;\n\t\t\t\t\t60(\n\t\t\t\t\t2):\n\t\t\t\t\t285\u2013\n\t\t\t\t\t288."},{"issue":"11","key":"i1551-6776-26-8-857-b11","series-title":"J Clin Microbiol","first-page":"3542","article-title":"Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum","volume":"50","year":"2012","unstructured":"Waites\n              KB,\n            \n            \n              Duffy\n              LB,\n            \n            \n              Bebear\n              CM,\n            \n            \n              Matlow\n              A.\n            \n          \n          Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum.\n\t\t\t\t\tJ Clin Microbiol.\n\t\t\t\t\t2012;\n\t\t\t\t\t50(\n\t\t\t\t\t11):\n\t\t\t\t\t3542\u2013\n\t\t\t\t\t3547."},{"issue":"5","key":"i1551-6776-26-8-857-b12","series-title":"J Antimicrob Chemother","first-page":"669","article-title":"Application of fluoroquinolone pharmacodynamics","volume":"46","year":"2000","unstructured":"Wright\n              DH,\n            \n            \n              Brown\n              GH,\n            \n            \n              Peterson\n              ML,\n            \n            \n              Rotschafer\n              JC.\n            \n          \n          Application of fluoroquinolone pharmacodynamics.\n\t\t\t\t\tJ Antimicrob Chemother.\n\t\t\t\t\t2000;\n\t\t\t\t\t46(\n\t\t\t\t\t5):\n\t\t\t\t\t669\u2013\n\t\t\t\t\t683."},{"issue":"9","key":"i1551-6776-26-8-857-b13","series-title":"JAMA Pediatr","first-page":"897","article-title":"Early, accurate diagnosis and early intervention in cerebral palsy: advances in diagnosis and treatment","volume":"171","year":"2017","unstructured":"Novak\n              I,\n            \n            \n              Morgan\n              C,\n            \n            \n              Adde\n              L,\n            \n          \n          .\n\t\t\t\t\tEarly, accurate diagnosis and early intervention in cerebral palsy: advances in diagnosis and treatment.\n\t\t\t\t\tJAMA Pediatr.\n\t\t\t\t\t2017;\n\t\t\t\t\t171(\n\t\t\t\t\t9):\n\t\t\t\t\t897\u2013\n\t\t\t\t\t907."},{"issue":"5","key":"i1551-6776-26-8-857-b14","series-title":"Eur J Ped Neurol","first-page":"408","article-title":"The predictive validity of general movements--a systematic review","volume":"13","year":"2009","unstructured":"Burger\n              M,\n            \n            \n              Louw\n              QA.\n            \n          \n          The predictive validity of general movements--a systematic review.\n\t\t\t\t\tEur J Ped Neurol.\n\t\t\t\t\t2009;\n\t\t\t\t\t13(\n\t\t\t\t\t5):\n\t\t\t\t\t408\u2013\n\t\t\t\t\t420."},{"issue":"6","key":"i1551-6776-26-8-857-b15","series-title":"Dev Med Child Neurol","first-page":"618","article-title":"Fidgety movements in infants born very preterm: predictive value for cerebral palsy in a clinical multicentre setting","volume":"59","year":"2017","unstructured":"Datta\n              AN,\n            \n            \n              Furrer\n              MA,\n            \n            \n              Bernhardt\n              I,\n            \n            \n              Huppi\n              PS.\n            \n          \n          Fidgety movements in infants born very preterm: predictive value for cerebral palsy in a clinical multicentre setting.\n\t\t\t\t\tDev Med Child Neurol.\n\t\t\t\t\t2017;\n\t\t\t\t\t59(\n\t\t\t\t\t6):\n\t\t\t\t\t618\u2013\n\t\t\t\t\t624."},{"issue":"10","key":"i1551-6776-26-8-857-b16","series-title":"J Clin Med","first-page":"1616","article-title":"Cerebral palsy: early markers of clinical phenotype and functional outcomes","volume":"8","year":"2019","unstructured":"Einspieler\n              C,\n            \n            \n              Bos\n              AF,\n            \n            \n              Krieber-Tomantschger\n              M,\n            \n          \n          .\n\t\t\t\t\tCerebral palsy: early markers of clinical phenotype and functional outcomes.\n\t\t\t\t\tJ Clin Med.\n\t\t\t\t\t2019;\n\t\t\t\t\t8(\n\t\t\t\t\t10):\n\t\t\t\t\t1616."},{"issue":"3","key":"i1551-6776-26-8-857-b17","series-title":"Dev Med Child Neurol","first-page":"240","article-title":"Use of the Hammersmith Infant Neurological Examination in infants with cerebral palsy: a critical review of the literature","volume":"58","year":"2016","unstructured":"Romeo\n              DM,\n            \n            \n              Ricci\n              D,\n            \n            \n              Brogna\n              C,\n            \n            \n              Mercuri\n              E.\n            \n          \n          Use of the Hammersmith Infant Neurological Examination in infants with cerebral palsy: a critical review of the literature.\n\t\t\t\t\tDev Med Child Neurol.\n\t\t\t\t\t2016;\n\t\t\t\t\t58(\n\t\t\t\t\t3):\n\t\t\t\t\t240\u2013\n\t\t\t\t\t245."},{"article-title":"Lexicomp Pediatric and Neonatal Lexi-Drugs. Clindamycin (systemic): Pediatric drug information","year":"2020","key":"i1551-6776-26-8-857-b18","unstructured":"Lexicomp Pediatric and Neonatal Lexi-Drugs. Clindamycin (systemic): Pediatric drug information.\n\t\t\t\t\t[online database].Hudson, OH:\n\t\t\t\t\t2020.\n\t\t\t\t\thttp:\/\/online.lexi.com. Subscription required to view. Accessed December 24, 2020."},{"year":"2018","series-title":"Red Book: 2018 Report of the Committee on Infectious Diseases","key":"i1551-6776-26-8-857-b19","unstructured":"Kimberlin\n              DW,\n            \n            \n              Brady\n              MT,\n            \n            \n              Jackson\n              MA\n            \n          ,\n\t\t\t\t\teds.Red Book: 2018 Report of the Committee on Infectious Diseases.\n\t\t\t\t\t31st ed.\n\t\t\t\t\tItasca, IL:\n\t\t\t\t\tAmerican Academy of Pediatrics;\n\t\t\t\t\t2018."},{"year":"2019","series-title":"Ureaplasma\/Mycoplasma--culture and reference identification","key":"i1551-6776-26-8-857-b20","unstructured":"Public Health Ontario.\n          \n          \n            Ureaplasma\/Mycoplasma--culture and reference identification.\n\t\t\t\t\t2019.\n\t\t\t\t\thttps:\/\/www.publichealthontario.ca\/en\/laboratory-services\/test-information-index\/ureaplasma-mycoplasma-culture-reference-id. Accessed August 1, 2020."},{"issue":"3","key":"i1551-6776-26-8-857-b21","series-title":"Expert Opin Drug Saf","first-page":"367","article-title":"Revisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation","volume":"15","year":"2016","unstructured":"Cross\n              R,\n            \n            \n              Ling\n              C,\n            \n            \n              Day\n              NPJ,\n            \n          \n          .\n\t\t\t\t\tRevisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation.\n\t\t\t\t\tExpert Opin Drug Saf.\n\t\t\t\t\t2016;\n\t\t\t\t\t15(\n\t\t\t\t\t3):\n\t\t\t\t\t367\u2013\n\t\t\t\t\t283."},{"issue":"12","key":"i1551-6776-26-8-857-b22","series-title":"Pediatr Infect Dis J","first-page":"1137","article-title":"Ciprofloxacin treatment in preterm neonates in bangladesh lack of effects on growth and development","volume":"25","year":"2006","unstructured":"Ahmed\n              ANU,\n            \n            \n              Khan\n              NZ,\n            \n            \n              Saha\n              SK,\n            \n          \n          .\n\t\t\t\t\tCiprofloxacin treatment in preterm neonates in bangladesh lack of effects on growth and development.\n\t\t\t\t\tPediatr Infect Dis J.\n\t\t\t\t\t2006;\n\t\t\t\t\t25(\n\t\t\t\t\t12):\n\t\t\t\t\t1137\u2013\n\t\t\t\t\t1141."},{"issue":"8","key":"i1551-6776-26-8-857-b23","series-title":"Pediatr Infect Dis J","first-page":"e183","article-title":"The pharmacokinetics of moxifloxacin in cerebrospinal fluid following intravenous administration: report of successfully treated infant with Mycoplasma hominis meningitis","volume":"39","year":"2020","unstructured":"Nohren\n              J,\n            \n            \n              Namtu\n              K,\n            \n            \n              Peloquin\n              C,\n            \n          \n          .\n\t\t\t\t\tThe pharmacokinetics of moxifloxacin in cerebrospinal fluid following intravenous administration: report of successfully treated infant with Mycoplasma hominis meningitis.\n\t\t\t\t\tPediatr Infect Dis J.\n\t\t\t\t\t2020;\n\t\t\t\t\t39(\n\t\t\t\t\t8):\n\t\t\t\t\te183\u2013\n\t\t\t\t\te184."},{"issue":"7","key":"i1551-6776-26-8-857-b24","series-title":"Pediatr Infect Dis J.","first-page":"749","article-title":"Successful whole genome sequencing-guided treatment of Myco-plasma hominis ventriculitis in a preterm infant","volume":"38","year":"2019","unstructured":"Scaggs-Huang\n              FA,\n            \n            \n              Mortensen\n              J,\n            \n            \n              Skoch\n              J,\n            \n          \n          .\n\t\t\t\t\tSuccessful whole genome sequencing-guided treatment of Myco-plasma hominis ventriculitis in a preterm infant.\n\t\t\t\t\tPediatr Infect Dis J.2019;\n\t\t\t\t\t38(\n\t\t\t\t\t7):\n\t\t\t\t\t749\u2013\n\t\t\t\t\t751."},{"issue":"4","key":"i1551-6776-26-8-857-b25","series-title":"J Pediatr Pharmacol Ther","first-page":"251","article-title":"Mycoplasma hominis meningitis in a 24 week premature neonate: case report and short literature review","volume":"13","year":"2008","unstructured":"Watson\n              L,\n            \n            \n              Pang\n              YM,\n            \n            \n              Mitchell\n              S\n            \n          \n          .\n\t\t\t\t\tMycoplasma hominis meningitis in a 24 week premature neonate: case report and short literature review.\n\t\t\t\t\tJ Pediatr Pharmacol Ther2008;\n\t\t\t\t\t13(\n\t\t\t\t\t4):\n\t\t\t\t\t251\u2013\n\t\t\t\t\t254."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/26\/8\/article-p857.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/jppt\/article-pdf\/26\/8\/857\/3019001\/i1551-6776-26-8-857.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/26\/8\/article-p857.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/26\/8\/article-p857.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:45:05Z","timestamp":1747356305000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/26\/8\/article-p857.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":25,"journal-issue":{"issue":"8"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-26.8.857","relation":{},"ISSN":["1551-6776"],"issn-type":[{"type":"print","value":"1551-6776"}],"subject":[],"published":{"date-parts":[[2021]]}}}